Indivior Pharmaceuticals, Inc 6-K, filed Jun 21, 2023
Indivior Pharmaceuticals, Inc. (INDV)
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on June 21, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: June 21, 2023
Commission File Number: 001-37835
Indivior PLC
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
| Exhibit No. |
Description of Exhibit | |
| 99.1 | Announcement sent to the London Stock Exchange on June 21, 2023, titled “Holding(s) in Company”. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Indivior PLC | ||||||
| Date: June 21, 2023 | /s/ Kathryn Hudson | |||||
| Name: Kathryn Hudson | ||||||
| Title: Company Secretary | ||||||
Exhibit 99.1
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | ||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: | Indivior PLC | |||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) | ||||||
| Non-UK issuer | ||||||
| 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) | ||||||
| An acquisition or disposal of voting rights | ☒ | |||||
| An acquisition or disposal of financial instruments | ||||||
| An event changing the breakdown of voting rights | ||||||
| Other (please specify) iii: | ||||||
| 3. Details of person subject to the notification obligation iv | ||||||
| Name | Scopia Capital Management LP Scopia Management, Inc. | |||||
| City and country of registered office (if applicable) | Wilmington, Delaware, United States (Scopia Capital Management LP) New York, New York, United States (Scopia Management, Inc.) | |||||
| 4. Full name of shareholder(s) (if different from 3.) v | ||||||
| Name | Goldman Sachs & Co. Morgan Stanley & Co., LLC | |||||
| City and country of registered office (if applicable) | Wilmington, Delaware, United States | |||||
| 5. Date on which the threshold was crossed or reached vi: | 19 June 2023 | |||||
| 6. Date on which issuer notified (DD/MM/YYYY): | 21 June 2023 | |||||
| 7. Total positions of person(s) subject to the notification obligation | ||||||
| % of voting rights attached to |
% of voting rights through |
Total of both in % (8.A + 8.B) |
Total number of voting rights | |||||
| Resulting situation on the date on which threshold was crossed or reached | 6.96% | Not Applicable | 6.96% | 9,590,921 | ||||
| Position of previous notification (if applicable) | 8.98% | Not Applicable | 8.98% | |||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii | ||||||||
| A: Voting rights attached to shares | ||||||||
| Class/type of ISIN code (if possible) |
Number of voting rights ix |
% of voting rights | ||||||
| Direct (DTR5.1) |
Indirect (DTR5.2.1) |
Direct (DTR5.1) |
Indirect (DTR5.2.1) | |||||
| GB00BRS65X63 | 9,590,921 | 6.96% | ||||||
| SUBTOTAL 8. A | 9,590,921 | 6.96% | ||||||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||||||||||
| Type of financial |
Expiration |
Exercise/ |
Number of voting exercised/converted. |
% of voting rights | ||||||||
| Not Applicable | ||||||||||||
| SUBTOTAL 8. B 1 | ||||||||||||
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) | ||||||||||||
| Type of financial |
Expiration |
Exercise/ |
Physical or cash Settlement xii |
Number of voting |
% of voting rights | |||||||
| Not Applicable | ||||||||||||
| SUBTOTAL 8.B.2 | ||||||||||||
| 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) | ||||||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii | ||||||||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv |
☒ | |||||||
| Name xv |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold | |||
| Scopia Management, Inc. | 6.96% | Not Applicable | 6.96% | |||
| Scopia Capital Management LP | 6.96% | Not Applicable | 6.96% | |||
| 10. In case of proxy voting, please identify: | ||||||
| Name of the proxy holder | ||||||
| The number and % of voting rights held | ||||||
| The date until which the voting rights will be held | ||||||
| 11. Additional information xvi | ||||||
| Place of completion | New York, NY, United States | |
| Date of completion | 21 June 2023 |